Page last updated: 2024-09-03

pd 135158 and Disease Models, Animal

pd 135158 has been researched along with Disease Models, Animal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
GuimarĂ£es, FS; Netto, CF1
Akiyoshi, J; Hikichi, T; Isogawa, K; Kouno, Y; Nagayama, H; Tsutsumi, T1

Other Studies

2 other study(ies) available for pd 135158 and Disease Models, Animal

ArticleYear
Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2004, Volume: 29, Issue:1

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Appetite Depressants; Cell Count; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Hormone Antagonists; Immunohistochemistry; Indoles; Male; Maze Learning; Meglumine; Microinjections; Neurons; Periaqueductal Gray; Proglumide; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Sincalide; Superior Colliculi; Time Factors

2004
[Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158].
    Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 1998, Volume: 18, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Conditioning, Psychological; Disease Models, Animal; Indoles; Male; Meglumine; Panic Disorder; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin

1998